Antibiotic Treatment Guidelines

Introduction to Cephalosporins

• Cephalosporins, such as cefpodoxime and cefixime, are effective against various bacterial infections, with cefpodoxime being superior to cefixime for respiratory infections due to its better activity against Staphylococcus aureus and drug-resistant Streptococcus pneumoniae, while cefixime is preferred for urinary tract and certain sexually transmitted infections due to its higher activity against Enterobacteriaceae 1, 2

Respiratory Infections

• The American Academy of Allergy and Clinical Immunology recommends cefpodoxime for acute bacterial sinusitis, and it has efficacy comparable to parenteral ceftriaxone in bronchopneumonia 1
• Cefdinir is suitable for mild to moderate respiratory tract infections, including acute otitis media, and can be used as an alternative treatment for patients in whom treatment with high-dose amoxicillin or amoxicillin/clavulanate fails or is not tolerated, according to the American Academy of Otolaryngology-Head and Neck Surgery and the Journal of Allergy and Clinical Immunology 3, 1

Urinary Tract Infections

• Cefixime is often preferred for uncomplicated UTIs due to its higher activity against Enterobacteriaceae, with a recommended regimen of 400 mg orally for gonorrhea treatment, resulting in cure rates for urogenital and rectal infection: 96.5% (CI = 94.8%--98.9%) 2

Sexually Transmitted Infections

• Cefixime (400 mg orally) is recommended for gonorrhea treatment, but has poor efficacy in pharyngeal infection: 78.9% (CI = 54.5%--94%), while cefpodoxime (200 mg) is less active against N. gonorrhoeae than cefixime 2

Pediatric Infections

• Both cefpodoxime and cefixime are effective in pediatric infections, but cefpodoxime may have better taste acceptance, and cefdinir suspension is well-tolerated and has good taste acceptance among children, as reported by the American Academy of Otolaryngology-Head and Neck Surgery 3, 1

Adverse Effects and Pharmacokinetics

• Cefpodoxime has a lower incidence of adverse effects with twice daily dosing (200 mg) compared to once daily (400 mg), while cefixime has mild to moderate gastrointestinal disturbances in 4-15% of patients, but no high prevalence of serum sickness-like reactions 1
• Cefdinir is not appreciably metabolized and is primarily eliminated via renal excretion, and has a favorable safety profile, being generally well tolerated in clinical trials, according to the American Academy of Otolaryngology-Head and Neck Surgery 3
• Ceftriaxone accumulates 15-36% with multiple dosing, allowing for once-daily dosing due to its long elimination half-life, and is used for serious bacterial infections requiring parenteral therapy, meningitis, bacteremia/septicemia, and complicated infections requiring hospitalization 3

Treatment Recommendations

• For respiratory infections, choose cefpodoxime if S. aureus is suspected or confirmed, and consider cefdinir as an alternative treatment for patients in whom treatment with high-dose amoxicillin or amoxicillin/clavulanate fails or is not tolerated 1, 3
• For urinary tract infections, choose cefixime for uncomplicated UTIs, especially those caused by Enterobacteriaceae, and for gonorrhea, choose cefixime (400 mg) over cefpodoxime, particularly for pharyngeal infections 2
• The degree of cross-reactivity between penicillins and third-generation cephalosporins like cefdinir and ceftriaxone is negligible due to their distinct chemical structures, according to the American Academy of Pediatrics 4